Siirry suoraan sisältöön
Progress in Molecular Biology and Translational Science
Tallenna

Progress in Molecular Biology and Translational Science

Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B, Volume 163 in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research topics related to Glycans and glycosaminoglycans as clinical biomarkers and therapeutics. Topics in this update include an Overview of Fugal Glycan-based Therapeutics, Heparin: An Essential Drug for Modern Medicine, Low Molecular Weight Heparins and Their Clinical Applications, The Clinical Use of Fondaparinux: A Synthetic Heparin Pentasaccharid, Heparinoids as Clinically Used Drugs, Marine Glycan-Derived Therapeutics in China, Efficacy of Heparinoid PSS in Treating Cardiovascular and other Diseases—30 Years Clinical Applications in China, and more.
Alaotsikko
Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics Part B
Toimittaja
Lijuan Zhang
ISBN
9780128177402
Kieli
englanti
Paino
970 grammaa
Julkaisupäivä
26.4.2019
Sivumäärä
551